Nienke M Kosse1, Petra J C Heesterbeek2, Koen C Defoort3, Ate B Wymenga3, Gijs G van Hellemondt3. 1. Sint Maartenskliniek Research, Sint Maartenskliniek, P.O. box 9011, 6500 GM, Nijmegen, The Netherlands. n.m.kosse@gmail.com. 2. Sint Maartenskliniek Research, Sint Maartenskliniek, P.O. box 9011, 6500 GM, Nijmegen, The Netherlands. p.heesterbeek@maartenskliniek.nl. 3. Department of Orthopedic Surgery, Sint Maartenskliniek, Nijmegen, The Netherlands.
Abstract
INTRODUCTION: Physiological motion after total knee arthroplasty (TKA) should result in a large range of motion, which would lead to good clinical outcomes. An adjusted design of a bicruciate-stabilizing TKA was developed to reproduce physiological motion. The aim of this study was to (1) investigate the maximal knee flexion of this knee system, 1 year post-operatively; (2) determine the clinical and functional improvement and compare the outcomes between patients with and without high maximal flexion; and (3) evaluate the adverse events. MATERIALS AND METHODS: In this prospective study, 62 patients with osteoarthritis received a bicruciate-stabilizing TKA. Maximum flexion was measured on a lateral X-ray pre- and post-operatively. Clinical and functional scores and the adverse events were reported up until 2 years after surgery. RESULTS: Pre-operatively, the median (range) maximal flexion was 131.5 (90-153)° and 1 year post-operatively, it was 130 (82-150)°. The results for the clinical scores showed an improvement between pre-operative values and post-operative values. The Kujala score and Knee Osteoarthritis Outcome Score (KOOS) symptoms, sport and quality of life score were better in patients with high maximal flexion (≥ 125°). Ten (serious) adverse device events were reported. CONCLUSIONS: In conclusion, the bicruciate-stabilizing TKA obtained a maximal flexion comparable to the flexion pre-operatively and resulted in good clinical and functional outcomes. Patients with high flexion ability seem to perform better on clinical and functional outcomes. Furthermore, the adjusted design of the bicruciate-stabilizing TKA reduced the number of adverse events. LEVEL OF EVIDENCE: Prospective cohort study, Level II.
INTRODUCTION: Physiological motion after total knee arthroplasty (TKA) should result in a large range of motion, which would lead to good clinical outcomes. An adjusted design of a bicruciate-stabilizing TKA was developed to reproduce physiological motion. The aim of this study was to (1) investigate the maximal knee flexion of this knee system, 1 year post-operatively; (2) determine the clinical and functional improvement and compare the outcomes between patients with and without high maximal flexion; and (3) evaluate the adverse events. MATERIALS AND METHODS: In this prospective study, 62 patients with osteoarthritis received a bicruciate-stabilizing TKA. Maximum flexion was measured on a lateral X-ray pre- and post-operatively. Clinical and functional scores and the adverse events were reported up until 2 years after surgery. RESULTS: Pre-operatively, the median (range) maximal flexion was 131.5 (90-153)° and 1 year post-operatively, it was 130 (82-150)°. The results for the clinical scores showed an improvement between pre-operative values and post-operative values. The Kujala score and Knee Osteoarthritis Outcome Score (KOOS) symptoms, sport and quality of life score were better in patients with high maximal flexion (≥ 125°). Ten (serious) adverse device events were reported. CONCLUSIONS: In conclusion, the bicruciate-stabilizing TKA obtained a maximal flexion comparable to the flexion pre-operatively and resulted in good clinical and functional outcomes. Patients with high flexion ability seem to perform better on clinical and functional outcomes. Furthermore, the adjusted design of the bicruciate-stabilizing TKA reduced the number of adverse events. LEVEL OF EVIDENCE: Prospective cohort study, Level II.
Authors: Florian Baumann; Werner Krutsch; Michael Worlicek; Maximilian Kerschbaum; Johannes Zellner; Paul Schmitz; Michael Nerlich; Carsten Tibesku Journal: Arch Orthop Trauma Surg Date: 2017-11-09 Impact factor: 3.067
Authors: Richard D Komistek; Jerome Allain; Dylan T Anderson; Douglas A Dennis; Daniel Goutallier Journal: Clin Orthop Relat Res Date: 2002-11 Impact factor: 4.176
Authors: Trevor F Grieco; Adrija Sharma; Garett M Dessinger; Harold E Cates; Richard D Komistek Journal: J Arthroplasty Date: 2017-09-25 Impact factor: 4.757
Authors: Jean-Noel Argenson; Sebastien Parratte; Abdullah Ashour; Richard D Komistek; Giles R Scuderi Journal: Clin Orthop Relat Res Date: 2008-08-15 Impact factor: 4.176